Cited by 235Cancer, Hypoxia, and MetabolismEar and Head TumorsAngiogenesis and VEGF in Cancer

The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.

Failure to prolyl hydroxylate hypoxia‐inducible factor α phenocopies VHL inactivation in vivo

Open access

Abstract

Many functions have been assigned to the von Hippel-Lindau tumor suppressor gene product (pVHL), including targeting the alpha subunits of the heterodimeric transcription factor HIF (hypoxia-inducible factor) for destruction. The binding of pVHL to HIFalpha requires that HIFalpha be hydroxylated on one of two prolyl residues. We introduced HIF1alpha and HIF2alpha variants that cannot be hydroxylated on these sites into the ubiquitously expressed ROSA26 locus along with a Lox-stop-Lox cassette that renders their expression Cre-dependent. Expression of the HIF2alpha variant in the skin and liver induced changes that were highly similar to those seen when pVHL is lost in these organs. Dual expression of the HIF1alpha and HIF2alpha variants in liver, however, more closely phenocopied the changes seen after pVHL inactivation than did the HIF2alpha variant alone. Moreover, gene expression profiling confirmed that the genes regulated by HIF1alpha and HIF2alpha in the liver are overlapping but non-identical. Therefore, the pathological changes caused by pVHL inactivation in skin and liver are due largely to dysregulation of HIF target genes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/sj.emboj.7601300

Cites

58 of 58 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 58 references

Cited by

Sorted by citations

Items 101–200 of 235

Metadata

Authors
Kim, W. Y., Safran, M., Buckley, M. R., Ebert, B. L., Glickman, J., Bosenberg, M., Regan, M., & Kaelin, W. G.
Affiliations
  • Brigham and Women's Hospital (US)
  • Broad Institute (US)
  • University of Vermont (US)
  • Harvard University (US)
Corresponding author
Kaelin, William G
Venue
The EMBO Journal
Published
2006-09-14
Volume
25
Issue
19
Pages
4650-4662
ISSN
  • 0261-4189 (ISSN-L)
  • 1460-2075
OpenAlex
W2097654747
Cited by
235
References
58
Citations by year
2026: 3 · 2025: 5 · 2024: 13 · 2023: 11 · 2022: 9 · 2021: 11 · 2020: 10 · 2019: 12 · 2018: 13 · 2017: 6 · 2016: 10 · 2015: 10 · 2014: 25 · 2013: 14 · 2012: 12
FWCI
6.01
Type
journal article
Language
en
Open access
Locations
  • The EMBO Journal (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Howard Hughes Medical Institute
  • National Institutes of Health
  • National Cancer Institute (T32CA009172)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
  • Health Sciences › Medicine › Oncology › Ear and Head Tumors
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
Keywords
von Hippel-Lindau tumor suppressor, hypoxia-inducible factor alpha, HIF-1α, HIF-2α, prolyl hydroxylation, phenocopy, Rosa26 locus, Cre-loxP system, liver, skin, HIF target genes, gene expression profiling, tumor suppressor inactivation
MeSH terms
Epidermal Cells, Endothelial PAS Domain-Containing Protein 1, Animals, Blood Vessels, Body Weight, Epidermis, Gene Expression Regulation, HeLa Cells, Humans, Hydroxylation, Liver, Mice, Inbred BALB C, Mice, Mutant Strains, Organ Size, Phenotype, Proline, Recombination, Genetic, Hepatocytes, Cell Proliferation, Mice, Basic Helix-Loop-Helix Proteins, Basic Helix-Loop-Helix Transcription Factors, Von Hippel-Lindau Tumor Suppressor Protein, Hypoxia-Inducible Factor 1, alpha Subunit

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review